Cargando…
Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730510/ https://www.ncbi.nlm.nih.gov/pubmed/36504640 http://dx.doi.org/10.3389/fneur.2022.1013819 |
_version_ | 1784845688574574592 |
---|---|
author | Cao, Jie Xing, Pengfei Zhu, Xucheng Chen, Ronghua Shao, Huaming Xuan, Jinggang Jiang, Tianwei Yang, Pengfei Zhang, Yongwei Li, Zifu Chen, Wenhuo Li, Tianxiao Wang, Shouchun Lou, Min Peng, Ya Liu, Jianmin |
author_facet | Cao, Jie Xing, Pengfei Zhu, Xucheng Chen, Ronghua Shao, Huaming Xuan, Jinggang Jiang, Tianwei Yang, Pengfei Zhang, Yongwei Li, Zifu Chen, Wenhuo Li, Tianxiao Wang, Shouchun Lou, Min Peng, Ya Liu, Jianmin |
author_sort | Cao, Jie |
collection | PubMed |
description | BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize Acute Ischaemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals (DIRECT-MT). The primary outcome was the 90-day modified Rankin Scale (mRS) score. Five subgroups of cardioembolic stroke patients were analyzed. A multivariable ordinal logistic regression analysis analyzed the difference in the primary outcome between the direct mechanical thrombectomy (MT) and bridging therapy groups. An interaction term was entered into the model to test for subgroup interaction. The DIRECT-MT trial is registered with clinicaltrials.gov Identifier: NCT03469206. RESULTS: A total of 290 CE stroke patients from the DIRECT-MT trial were enrolled in this study: 146 patients in the direct MT group and 144 patients in the bridging therapy group. No difference between the two treatment groups in the primary outcome was found (adjusted common odds ratio, 1.218; 95% confidence interval, 0.806 to 1.841; P = 0.34). In the subgroup analysis, CE stroke patients with an NIHSS ≤ 15 in the direct MT group were associated with better outcomes (47 vs. 53, acOR, 3.14 [1.497, 6.585]) and lower mortality (47 vs. 53, aOR, 0.16 [0.026, 0.986]) than those in the bridging therapy group, while there were no significant differences between the two treatment groups in the outcome and mortality of CE stroke patients with an NIHSS >15. CONCLUSION: Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy. This need to be confirmed by further prospective studies in a larger number of patients. |
format | Online Article Text |
id | pubmed-9730510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97305102022-12-09 Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) Cao, Jie Xing, Pengfei Zhu, Xucheng Chen, Ronghua Shao, Huaming Xuan, Jinggang Jiang, Tianwei Yang, Pengfei Zhang, Yongwei Li, Zifu Chen, Wenhuo Li, Tianxiao Wang, Shouchun Lou, Min Peng, Ya Liu, Jianmin Front Neurol Neurology BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize Acute Ischaemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals (DIRECT-MT). The primary outcome was the 90-day modified Rankin Scale (mRS) score. Five subgroups of cardioembolic stroke patients were analyzed. A multivariable ordinal logistic regression analysis analyzed the difference in the primary outcome between the direct mechanical thrombectomy (MT) and bridging therapy groups. An interaction term was entered into the model to test for subgroup interaction. The DIRECT-MT trial is registered with clinicaltrials.gov Identifier: NCT03469206. RESULTS: A total of 290 CE stroke patients from the DIRECT-MT trial were enrolled in this study: 146 patients in the direct MT group and 144 patients in the bridging therapy group. No difference between the two treatment groups in the primary outcome was found (adjusted common odds ratio, 1.218; 95% confidence interval, 0.806 to 1.841; P = 0.34). In the subgroup analysis, CE stroke patients with an NIHSS ≤ 15 in the direct MT group were associated with better outcomes (47 vs. 53, acOR, 3.14 [1.497, 6.585]) and lower mortality (47 vs. 53, aOR, 0.16 [0.026, 0.986]) than those in the bridging therapy group, while there were no significant differences between the two treatment groups in the outcome and mortality of CE stroke patients with an NIHSS >15. CONCLUSION: Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy. This need to be confirmed by further prospective studies in a larger number of patients. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9730510/ /pubmed/36504640 http://dx.doi.org/10.3389/fneur.2022.1013819 Text en Copyright © 2022 Cao, Xing, Zhu, Chen, Shao, Xuan, Jiang, Yang, Zhang, Li, Chen, Li, Wang, Lou, Peng and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Cao, Jie Xing, Pengfei Zhu, Xucheng Chen, Ronghua Shao, Huaming Xuan, Jinggang Jiang, Tianwei Yang, Pengfei Zhang, Yongwei Li, Zifu Chen, Wenhuo Li, Tianxiao Wang, Shouchun Lou, Min Peng, Ya Liu, Jianmin Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title | Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title_full | Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title_fullStr | Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title_full_unstemmed | Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title_short | Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) |
title_sort | mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: a subgroup analysis of a randomized clinical trial (direct-mt) |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730510/ https://www.ncbi.nlm.nih.gov/pubmed/36504640 http://dx.doi.org/10.3389/fneur.2022.1013819 |
work_keys_str_mv | AT caojie mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT xingpengfei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT zhuxucheng mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT chenronghua mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT shaohuaming mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT xuanjinggang mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT jiangtianwei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT yangpengfei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT zhangyongwei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT lizifu mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT chenwenhuo mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT litianxiao mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT wangshouchun mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT loumin mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT pengya mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt AT liujianmin mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt |